Page last updated: 2024-08-25

nsc 251635 and Neoplasms

nsc 251635 has been researched along with Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (66.67)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atassi, G; Brassinne, C; Coune, A; Frühling, J; Ghanem, G; Hildebrand, J; Laduron, C; Ruysschaert, JM; Sculier, JP; Stryckmans, P	1
Perez-Soler, R; Sugarman, SM	1
Atassi, G; Brassinne, C; Coune, A; Frühling, J; Laduron, C; Ruysschaert, JM; Sculier, JP	1

Reviews

1 review(s) available for nsc 251635 and Neoplasms

Article	Year
Liposomes in the treatment of malignancy: a clinical perspective. Critical reviews in oncology/hematology, 1992, Volume: 12, Issue:3 Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Antigens, Neoplasm; Antineoplastic Agents; Clinical Trials as Topic; Doxorubicin; Drug Carriers; Drug Evaluation; Drug Screening Assays, Antitumor; Humans; Immunotherapy; Liposomes; Macrophage Activation; Macrophages; Melanoma-Specific Antigens; Neoplasm Proteins; Neoplasms; Organoplatinum Compounds; Phosphatidylethanolamines; Quinazolines; Treatment Outcome	1992

Article

Year

Liposomes in the treatment of malignancy: a clinical perspective.

Critical reviews in oncology/hematology, 1992, Volume: 12, Issue:3

Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Antigens, Neoplasm; Antineoplastic Agents; Clinical Trials as Topic; Doxorubicin; Drug Carriers; Drug Evaluation; Drug Screening Assays, Antitumor; Humans; Immunotherapy; Liposomes; Macrophage Activation; Macrophages; Melanoma-Specific Antigens; Neoplasm Proteins; Neoplasms; Organoplatinum Compounds; Phosphatidylethanolamines; Quinazolines; Treatment Outcome

1992

Other Studies

2 other study(ies) available for nsc 251635 and Neoplasms

Article	Year
Iv administration of a water-insoluble antimitotic compound entrapped in liposomes. Preliminary report on infusion of large volumes of liposomes to man. Cancer treatment reports, 1983, Volume: 67, Issue:11 Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Carcinoma, Small Cell; Female; Humans; Infusions, Parenteral; Leukemia, Erythroblastic, Acute; Liposomes; Lung Neoplasms; Male; Middle Aged; Neoplasms; Quinazolines	1983
Intravenous infusion of high doses of liposomes containing NSC 251635, a water-insoluble cytostatic agent. A pilot study with pharmacokinetic data. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Drug Tolerance; Female; Humans; Infusions, Parenteral; Kinetics; Liposomes; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Quinazolines; Solubility	1986

Article

Year

Iv administration of a water-insoluble antimitotic compound entrapped in liposomes. Preliminary report on infusion of large volumes of liposomes to man.

Cancer treatment reports, 1983, Volume: 67, Issue:11

Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Carcinoma, Small Cell; Female; Humans; Infusions, Parenteral; Leukemia, Erythroblastic, Acute; Liposomes; Lung Neoplasms; Male; Middle Aged; Neoplasms; Quinazolines

1983

Intravenous infusion of high doses of liposomes containing NSC 251635, a water-insoluble cytostatic agent. A pilot study with pharmacokinetic data.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:5

Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Drug Tolerance; Female; Humans; Infusions, Parenteral; Kinetics; Liposomes; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Quinazolines; Solubility

1986